Tag: SIRFLOX
Right-side survival data from SIRFLOX/FOXFIRE global studies presented at WCGIC
Sirtex has announced the presentation of the SIRFLOX/FOXFIRE Global right-side survival data in metastatic colorectal cancer at the 19th European Society for Medical Oncology...
REsect study shows SIRT makes metastatic colorectal cancer patients more likely...
Metastatic colorectal cancer patients treated first-line with SIR-spheres Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, the REsect study...
New data show SIRT does not prolong overall survival in metastatic...
The FOXFIRE, SIRFLOX and FOXFIRE Global randomised studies evaluated the efficacy of combining first-line chemotherapy for metastatic colorectal cancer with selective internal radiotherapy (SIRT)...
